About APICES
APICES is a company based in Pinto (Spain) founded in 2009 was acquired by Magnum Partners in November 2021. APICES offers products and services including Biostatistics, Pharmacovigilance, Data Management, and Project Design. APICES operates in a competitive market with competitors including Charles River Laboratories, LabCorp, Cytel, Precision Medicine Group and Veeda Clinical Research, among others.
- Headquarter Pinto, Spain
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
European Union
& 1 more
-
Employee Count
Not available
-
Acquired by
Magnum Partners
(Nov 01, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of APICES
APICES offers a comprehensive portfolio of products and services, including Biostatistics, Pharmacovigilance, Data Management, and Project Design.
Provides statistical support for clinical studies and trials.
Manages drug safety and adverse event reporting in research.
Tailors data services for efficient clinical study needs.
Handles project definition and site selection for trials.
People of APICES
Unlock access to complete
Funding Insights of APICES
Investors in APICES
APICES has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Magnum Industrial Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A leading private equity firm focused on Iberian markets is operated.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for APICES
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by APICES
Investment portfolio details for APICES
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - APICES
Detailed financials for APICES
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Apices Comparisons
Peer comparison for APICES
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of APICES
APICES operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, LabCorp, Cytel, Precision Medicine Group and Veeda Clinical Research, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of drug discovery and preclinical development services
|
|
| Locked | Locked | Locked |
Provider of laboratory tests for physicians
|
|
| Locked | Locked | Locked |
Data analysis and statistical solutions are provided for life sciences.
|
|
| Locked | Locked | Locked |
Provider of clinical research, development, and commercialization services for life sciences
|
|
| Locked | Locked | Locked |
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare.
|
|
| Locked | Locked | Locked |
Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices
|
Detailed competitors of APICES
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Apices
Complete news archive for APICES
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about APICES
APICES was founded in 2009 and raised its 1st funding round 7 years after it was founded.
APICES is headquartered in Pinto, Spain. It is registered at Pinto, Madrid, Spain.
Oscar Salamanca is the current CEO of APICES.
APICES was established in 2009 and is based in Pinto, Spain. Operations focus on the contract research organization sector, where a range of diversified services is delivered to support research and development needs. The company operates within the biotechnology and pharmaceutical industries, offering expertise in clinical and preclinical activities. Leadership is provided by CEO Oscar Salamanca, with services tailored to international clients from the Spanish headquarters.
APICES's top competitors include LabCorp, Charles River Laboratories and Cytel.
APICES offers Biostatistics, Pharmacovigilance, Data Management, and Project Design.
APICES has 2 investors. Key investors include European Union, and Magnum Industrial Partners.